Ovarian Cancer Clinical Trials

A listing of Ovarian Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Birmingham Alabama 35233

A Phase 3 clinical study for patients with Ovarian Cancer or Ovarian Neoplasm, Fallopian Tube, or Primary Peritoneal Cancer

Huntsville Alabama 35805

A Phase 3 clinical study for patients with Ovarian Cancer or Ovarian Neoplasm, Fallopian Tube, or Primary Peritoneal Cancer

Mobile Alabama 36604

A Phase 3 clinical study for patients with Ovarian Cancer or Ovarian Neoplasm, Fallopian Tube, or Primary Peritoneal Cancer

Mobile Alabama 36604

Patients are needed to participate in a clinical research study of FANG Autologous Tumor Cell Immunotherapy and Placebo to evaluate Ovarian Cancer or Ovarian Neoplasms

UPDATED

Muscle Shoals Alabama 35661

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Alaska

Anchorage Alaska 99508

A Phase 3 clinical study for patients with Ovarian Cancer or Ovarian Neoplasm, Fallopian Tube, or Primary Peritoneal Cancer

Anchorage Alaska

Patients are needed to participate in a clinical research study evaluating cediranib and olaparib for the treatment of Recurrent Platinum Resistant Ovarian Cancer

Arizona

Arizona Oncology Associates
Phoenix Arizona

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

Arizona Oncology Associates
Tucson Arizona

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

View More ▼

Chandler Arizona

A clinical trial to evaluate treatments using Niraparib for patients with Ovarian Cancer

Chandler Arizona 85224

A Phase 3 clinical study for patients with Ovarian Cancer

UPDATED

Goodyear Arizona 85338

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Phoenix Arizona

A clinical trial to evaluate treatments using Niraparib for patients with Ovarian Cancer

UPDATED

Phoenix Arizona 85004

A Phase 3 clinical study for patients with Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer or Ovarian Cancer

Phoenix Arizona 85027

A Phase 3 clinical study for patients with Ovarian Cancer

Phoenix Arizona 85016

A Phase 3 clinical study for patients with Ovarian Cancer

Phoenix Arizona 85016

A Phase 3 clinical study for patients with Ovarian Cancer or Ovarian Neoplasm, Fallopian Tube, or Primary Peritoneal Cancer

Phoenix Arizona 85016

A Phase 3 clinical study for patients with Ovarian Cancer or Ovarian Neoplasm, Fallopian Tube, or Primary Peritoneal Cancer

Phoenix Arizona 85004

A Phase 3 clinical study for patients with Ovarian Cancer or Ovarian Neoplasm, Fallopian Tube, or Primary Peritoneal Cancer

UPDATED

Scottsdale Arizona 85259

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Scottsdale Arizona 85258

A Phase 3 clinical study for patients with Ovarian Cancer

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study evaluating CRS-207 and epacadostat (INCB024360) for the treatment of Platinum-resistant Ovarian Cancer, Platinum-resistant Fallopian Cancer or Platinum-resistant Peritoneal Cancer

UPDATED

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study evaluating Ferumoxytol followed by MM-398

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study evaluating PLX3397 and Pembrolizumab to treat Advance Melanoma and Other Solid Tumors

Scottsdale Arizona

Patients are needed to participate in a clinical research study of AZD1775 to evaluate Locally Advanced Solid Tumors or Metastatic Solid Tumors

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study of FPA008 and Nivolumab, Selected Advanced Cancers

Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study of MM-310

UPDATED

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study of niraparib and pembrolizumab, Triple-negative Breast Cancer or Ovarian Cancer (KEYNOTE-162)

Tucson Arizona

A clinical trial to evaluate treatments using Chemotherapy and Rucaparib for patients with Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Tucson Arizona

A clinical trial to evaluate treatments using Niraparib for patients with Ovarian Cancer

Tucson Arizona 85711

A Phase 3 clinical study for patients with Ovarian Cancer

Tucson Arizona 85704

A Phase 3 clinical study for patients with Ovarian Cancer

Tucson Arizona 85711

A Phase 3 clinical study for patients with Ovarian Cancer or Ovarian Neoplasm, Fallopian Tube, or Primary Peritoneal Cancer

Tucson Arizona 85724-5024

A Phase 3 clinical study for patients with Ovarian Cancer or Ovarian Neoplasm, Fallopian Tube, or Primary Peritoneal Cancer

Tucson Arizona 85711

A Phase 3 clinical study for patients with Ovarian Cancer or Ovarian Neoplasm, Fallopian Tube, or Primary Peritoneal Cancer

Tucson Arizona 85711

A Phase 3 clinical study for patients with Ovarian Cancer, Platinum Resistant/Refractory Ovarian Cancer

Tucson Arizona 85704

A Phase 3 clinical study for patients with Ovarian Cancer, Platinum Resistant/Refractory Ovarian Cancer

Tucson Arizona

Patients are needed to participate in a clinical research study of Niraparib and Placebo to evaluate Ovarian Cancer

Arkansas

Fayetteville Arkansas 72703

A Phase 3 clinical study for patients with Ovarian Cancer

Fayetteville Arkansas 72703

A Phase 3 clinical study for patients with Ovarian Cancer, Platinum Resistant/Refractory Ovarian Cancer

Little Rock Arkansas 72205

A Phase 3 clinical study for patients with Ovarian Cancer or Ovarian Neoplasm, Fallopian Tube, or Primary Peritoneal Cancer

Rogers Arkansas 72758

A Phase 3 clinical study for patients with Ovarian Cancer

Rogers Arkansas 72758

A Phase 3 clinical study for patients with Ovarian Cancer, Platinum Resistant/Refractory Ovarian Cancer

California

The Stanford Center for Clinical and Translational Education and Research Recruiting
Palo Alto California 94304

An Open-Label Study of Varlilumab and Nivolumab in Head and Neck, Ovarian, Renal, Colorectal and GBM Cancers

Sutter West Bay
San Francisco California

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

View More ▼

Burbank California

A clinical trial to evaluate treatments using Niraparib for patients with Ovarian Cancer

Concord California 94520

A Phase 3 clinical study for patients with Ovarian Cancer or Ovarian Neoplasm, Fallopian Tube, or Primary Peritoneal Cancer

Downey California

Patients are needed to participate in a clinical research study evaluating cediranib and olaparib for the treatment of Recurrent Platinum Resistant Ovarian Cancer